Nu Skin Enterprises, Inc. (NUS.F)
| Previous Close | 11.00 |
| Open | 11.30 |
| Bid | 11.40 x 20000 |
| Ask | 11.50 x 20000 |
| Day's Range | 11.30 - 11.30 |
| 52 Week Range | 11.00 - 35.00 |
| Volume | |
| Avg. Volume | 18 |
| Market Cap | 574.425M |
| Beta (5Y Monthly) | 1.10 |
| PE Ratio (TTM) | 70.62 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 0.22 (2.01%) |
| Ex-Dividend Date | Feb 23, 2024 |
| 1y Target Est | N/A |
- Business Wire
Nu Skin Enterprises to Announce First Quarter 2024 Financial Results
PROVO, Utah, April 03, 2024--Nu Skin Enterprises, Inc. (NYSE: NUS) today announced it will release first quarter 2024 results after the market closes on Wednesday, May 8. The Nu Skin management team will host a conference call with the investment community later that same day at 5 p.m. ET. During the call, management will discuss recent results and upcoming business initiatives.
- PR Newswire
Nu Skin Launches RenuSpa iO, a New Personalized Beauty and Wellness Device
Nu Skin Enterprises (NYSE: NUS), a global beauty and wellness leader, today introduced Nu Skin RenuSpa iO, a smart beauty and wellness device designed to promote overall wellness and body confidence through skin stimulation. RenuSpa iO is an FDA-cleared microcurrent body device and the latest innovation from the world's best-selling brand for beauty device systems for six consecutive years.*
- Business Wire
Nu Skin Enterprises Reports Fourth Quarter and Full-year 2023 Results Above Company Guidance
PROVO, Utah, February 14, 2024--Nu Skin Enterprises Inc. (NYSE: NUS) today announced fourth quarter and full-year 2023 results slightly above its latest guidance.
